This study further reiterates the clinical findings associated with ATAD3A pathogenic variation, including developmental delay, hypotonia, congenital cataracts, hypertrophic cardiomyopathy, and cerebellar atrophy. The gene discussed is ATAD3A; the disease is Cerebellar atrophy.